ArticleDermatology and therapy2020

Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity.

Massimiliano Scalvenzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.